Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Shares withheld for taxes EVP, Human Resources gave up 223 shares (to pay taxes)
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award Director acquired 890 shares (grant or award)
  4. 4 Grant or award Director acquired 890 shares (grant or award)
  5. 4 Grant or award Director acquired 890 shares (grant or award)
  6. 4 Grant or award Director acquired 1,470 shares (grant or award)
  7. 4 Grant or award Director acquired 890 shares (grant or award)
  8. 4 Grant or award Director acquired 890 shares (grant or award)
  9. 4 Grant or award Director acquired 890 shares (grant or award)
  10. 4 Grant or award Director acquired 890 shares (grant or award)
  11. 4 Grant or award Director acquired 890 shares (grant or award)
  12. 4 Grant or award Director acquired 890 shares (grant or award)
  13. 4 Grant or award Director acquired 890 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Director sold 2,434 shares at an average $295.22 ($718,574)
  16. 4 Shares withheld for taxes Chief Executive Officer gave up 2,150 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP, Research & Development gave up 538 shares (to pay taxes)
  18. 4 Shares withheld for taxes EVP Pharmaceutical Oper & Tech gave up 130 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP Chief Legal Off & Corp Sec gave up 689 shares (to pay taxes)
  20. 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 46 shares (to pay taxes)

Page 16 of 86 · 1,714 filings